Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTA Laboratories is a Turkey-based publicly traded biotechnology and diagnostics company focused on in vitro diagnostic products, microbiology media, molecular testing kits, and related laboratory consumables and instruments. The company develops and manufactures clinical and industrial microbiology products and Real-Time PCR assays, with products used by researchers, laboratories, and healthcare professionals. Its commercial portfolio includes pathogen detection and monitoring kits such as assays for Epstein-Barr virus, BK virus, JC virus, and HSV-1/2, alongside nucleic acid extraction products and microbiology control materials. RTA also has activity in veterinary and animal health distribution, including poultry vaccine distribution. Overall, the business appears to be a commercial-stage diagnostics and life-science tools company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTA Laboratories.